StockIQStockIQ.tech

Alkermes plc (ALKS) Stock Analysis

--

Free AI-powered analysis and research for Alkermes plc stock

Sector: Healthcare

Full ALKS report

Alkermes plc (ALKS) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze ALKS Now β†’

πŸ“° Latest Update

Alkermes (ALKS) Reports Q3 Earnings: What Key Metrics Have to Say

Alkermes (ALKS) reported Q3 earnings for September 2026, with revenue of $480.13 million, a 21.8% increase year-over-year, and an EPS of $0.09, down from $0.49 in the previous year. The revenue exceeded the Zacks Consensus Estimate by 3.05%, while the EPS surprised analysts positively by 212.5%. The stock has gained 5% over the past month, outperforming the Zacks S&P 500 composite, and currently holds a Zacks Rank #3 (Hold).

Read full article β†’

History

People also watch

REGN
Regeneron Pharmaceuticals Inc.
--
ABT
Abbott Laboratories
--
GILD
Gilead Sciences Inc.
--
NGNE
Neurogene Inc.
--
PTCT
PTC Therapeutics, Inc.
--